We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
-0.3%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$752M
AUM Growth
+$253M
(+51%)
Cap. Flow
+$268M
Cap. Flow
% of AUM
35.64%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,082
New
405
Increased
619
Reduced
41
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$17.4M |
| 2 |
Apple
AAPL
|
+$7.52M |
| 3 |
Broadcom
AVGO
|
+$6.81M |
| 4 |
Bausch Health
BHC
|
+$5.93M |
| 5 |
NBIS
Nebius Group N.V.
NBIS
|
+$4.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$2.86M |
| 2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
+$1.98M |
| 3 |
EGLE
Eagle Bulk Shipping Inc.
EGLE
|
+$1.84M |
| 4 |
ALTR
Altera Corp
ALTR
|
+$1.74M |
| 5 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Healthcare | 13.08% |
| 3 | Industrials | 11.83% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Henry Schein
HSIC
$9.82B
| $686K | 0.09% |
12,314
+1,107
| +10% | +$61.2K |
|
|
IM
302
DELISTED
Ingram Micro
IM
| $685K | 0.09% |
27,370
+1,345
| +5% | +$35.2K |
|
303
Valmont Industries
VMI
$9.53B
| $680K | 0.09% |
5,717
+206
| +4% | +$25.4K |
|
|
FRAN
304
DELISTED
Francesca's Holdings Corporation
FRAN
| $679K | 0.09% |
4,199
+155
| +4% | +$29.9K |
|
305
Molina Healthcare
MOH
$10.3B
| $678K | 0.09% |
9,639
+548
| +6% | +$36.6K |
|
|
AMSG
306
DELISTED
Amsurg Corp
AMSG
| $678K | 0.09% |
9,692
+462
| +5% | +$30.9K |
|
307
FTI Consulting
FCN
$4.18B
| $675K | 0.09% |
16,375
+802
| +5% | +$32K |
|
308
Itron
ITRI
$4.54B
| $675K | 0.09% |
19,607
+930
| +5% | +$33.8K |
|
|
ARRS
309
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $675K | 0.09% |
22,048
+994
| +5% | +$32.2K |
|
|
KG
310
Kestrel Group
KG
$69M
| $674K | 0.09% |
2,136
+110
| +5% | +$32.2K |
|
311
Insperity
NSP
$2.01B
| $674K | 0.09% |
26,500
+972
| +4% | +$25.4K |
|
|
AMED
312
DELISTED
Amedisys
AMED
| $672K | 0.09% |
16,924
+866
| +5% | +$27K |
|
313
DHI Group
DHX
$173M
| $672K | 0.09% |
75,621
+3,879
| +5% | +$33.7K |
|
314
Resources Connection
RGP
$145M
| $671K | 0.09% |
41,707
+1,537
| +4% | +$25.1K |
|
315
Merit Medical Systems
MMSI
$5.32B
| $670K | 0.09% |
31,107
+1,443
| +5% | +$29.3K |
|
|
ANH
316
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $669K | 0.09% |
135,617
+6,539
| +5% | +$33.8K |
|
|
STRZA
317
DELISTED
Starz - Series A
STRZA
| $668K | 0.09% |
14,932
+717
| +5% | +$28.5K |
|
|
CAM
318
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $668K | 0.09% |
12,759
+1,881
| +17% | +$97.5K |
|
319
Universal Health Services
UHS
$10.5B
| $664K | 0.09% |
4,676
+518
| +12% | +$64.9K |
|
|
CSH
320
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $663K | 0.09% |
25,306
+1,297
| +5% | +$34.4K |
|
|
EXPR
321
DELISTED
Express, Inc.
EXPR
| $662K | 0.09% |
1,826
+120
| +7% | +$41.9K |
|
322
Pitney Bowes
PBI
$2.39B
| $661K | 0.09% |
31,753
+3,436
| +12% | +$77.4K |
|
|
TECD
323
DELISTED
Tech Data Corp
TECD
| $661K | 0.09% |
11,476
+563
| +5% | +$33.9K |
|
|
AAN.A
324
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $658K | 0.09% |
18,163
+992
| +6% | +$35.9K |
|
|
HOLX
325
DELISTED
Hologic
HOLX
| $656K | 0.09% |
17,234
+1,731
| +11% | +$60.6K |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q2 2015 Portfolio in Review
As of Q2 2015, Vident Investment Advisory held 1,082 positions worth $752M, up 51% from $498M the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Vident Investment Advisory deployed $268M of net new capital in Q2 2015, opening 405 new positions and adding to 619 existing holdings. Its largest new stake was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $2.86M trimmed.
- Vident Investment Advisory's largest Q2 2015 buy was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
- Vident Investment Advisory added most to Apple in Q2 2015, an estimated $7.52M increase.
- Vident Investment Advisory's biggest Q2 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $2.86M.
- Vident Investment Advisory fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $1.98M.
- Vident Investment Advisory's ten largest holdings make up 9.6% of its $752M portfolio in Q2 2015.
- Vident Investment Advisory opened 405 new positions and closed 17 in Q2 2015.
- Vident Investment Advisory's portfolio value rose 51% quarter-over-quarter to $752M.
Based on Vident Investment Advisory's 13F filing for Q2 2015, filed 29 Jul 2015.